维普期刊资源整合服务平台（V6.5）

85篇 您的检索式：作者名="Channick RN"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Safety and efficacy of inhaled treprostinil as add-on therapy to bosentan in pulmonary arterial hypertension显示文摘	Channick RN Olschewski H Seeger W	2006	J Am Coll Cardiol2006，48，：	1
2	Endothelin antagonism in pulmonary arterial hypertension显示文摘	Lee SH Channick RN	2005	Semin Respir Crit Care Med2005，26，4：	1
3	Endothelin receptor antagonists in pulmonary arterial hypertension显示文摘	Channick RN Sitbon O Barst RJ	2004	J Am Coll Cardiol2004，43，：	1
4	Inhaled nitric oxide as a screening agent for safety identifying responders to oral calcium-channel blockers in primary pulmonary hypertension显示文摘	Sitbon O Badech DB Channick RN	1998	Eur Respir J1998，12，：	1
5	Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension:a 1-year follow up study显示文摘	Sitbon O Badesch DB Channick RN	2003	Chest2003，124，1：	1
6	Effects of the dual en- do-thelin-receptor antagonist bosentan in patients with pulmonary hy- pert-ension: a random-ised placebo controlled study 显示文摘	Channick RN Simonneau G Sitbon O	2001	Lancet2001，358，9288：	1
7	Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study 显示文摘	Simonneau G Sitbon O	2001	Lancet2001，358，9288：	1
8	Diagnosis, as-sessment ,and treatment of non - pulmonary arterial hypertensionpulmonary hypertension显示文摘	Hoeper MM Barbera JA Channick RN	2009	J Am Coll Cardiol2009，54，1：	1
9	Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterialhypertension:a 1-year follow up study显示文摘	Sitbon O Badesch DB Channick RN		0，，：	1
10	Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension:a randomised placebocontrolled study显示文摘	Channick RN Simonneau G Sitbon O	2001	Lancet2001，358，9288：	1
11	Orvnic 3hroml~etrt~c Pulrmnmy Hytx~ension: the End Result of Pulmonary Embolism 显示文摘	Witldn AS Channick RN	2015	Curt Cardiol Rep2015，17，8：	1
12	Macitentan and morbidity and mortality in pulmonary arterial hypertension显示文摘	Pulido T Adzerikho I Channick RN	2013	N Engl J Med2013，369，9：	1
13	Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study 显示文摘	Channick RN Simonneau G Sitbon O	2001	Lancet2001，358，：	1
14	Surgical treatments/interventions for pulmonary arterial hypertension:ACCP evidence-based clinical practice guidelines显示文摘	Doyle RL McCrory D Channick RN	2004	Chest2004，126，1：	1
15	Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonaryhy pertension:a randomised placebo-controlled study显示文摘	Channick RN。Simonneau G。Sitbon et a1	2001	Lancet2001，358，9288：	1
16	Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension显示文摘	Channick RN Simonneau G Sitbon O	2001	Lancet2001，358，：	1
17	Effects of the dual endothelin antagonist bosentan in patients with pulmonary arterial hypertension:A 1-year follow up study显示文摘	Sitbon O Badesch DB Channick RN	2003	Chest2003，124，13：	1
18	Effects of the dual endothelin-receptor antagonist bosentan in patients with pulnoary hypertensiont a randomized placebo-controlled study显示文摘	Channick RN Sinonneau G Sitbon O etal	2001	Lancet2001，358，：	1
19	Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study显示文摘	CHANNICK RN SIMONNEAU G SITBON O	2001	Lancet2001，358，9288：	1
20	Effects of the dualendothelin receptor antagonist bosentan in patients with pul-monary arterial hypertension : a 1-year follow-up study显示文摘	Sitbon O Badesch DB Channick RN	2003	Chest2003，124，1：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示